L&K Biomed Ltd. (KOSDAQ:156100)
South Korea flag South Korea · Delayed Price · Currency is KRW
13,930
-1,480 (-9.60%)
At close: Dec 5, 2025

L&K Biomed Company Description

L&K Biomed Ltd., a medical company, manufactures and sells spinal implants in South Korea, the United States, Thailand, and internationally.

The company offers spinal products comprising BlueEX-T, BluEX-TC, BluEX-A, BlueEX-L, and BluEX-ATP; BluEX-LT, an advanced lateral cage system for spinal lordosis restoration; PathLoc-TM, an expandable TLIF/PLIF lumbar cage system; AccelFix-XL, an expandable lateral lumbar cage system; AccelFix-XTP, an expandable lumbar cage system for anterior-to-psoas approach; and PathLoc-TA, an expandable ALIF anterior lumbar cage system.

It also provides CastleLoc-C, an anterior cervical interbody fusion cage; CastleLoc-P, an anterior cervical plate system; CastleLoc-S, a posterior cervical fixation system; AccelFix-S, a lumbar spinal fixation screw system; AccelFix-LP, a lumbar plate system; OpenLoc-L, a lumbar spinal fixation system; LnK Lumbar Peek Cages for posterior lumbar interbody fusion procedures; PathLoc-L, a MIS spinal system; AccelFix-MIS, a spinal fixation system; and PathLoc-SI sacroiliac fixation and fusion system that offers fusion and stabilization of the SI joint.

In addition, the company offers CastleLoc Pectus bar system for the correction of pectus excavatum. L&K Biomed Ltd. was founded in 2008 and is headquartered in Yongin-si, South Korea.

L&K Biomed Ltd.
Country South Korea
Founded 2008
Industry Electromedical and Electrotherapeutic Apparatus
Employees 60
CEO Guk-jin Kang

Contact Details

Address:
16-25, Dongbaekjungang-ro 16beon-gil
Yongin-si, 17015
South Korea
Phone 82 2 1600 0841
Website lnkbiomed.com

Stock Details

Ticker Symbol 156100
Exchange KOSDAQ
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency KRW
SIC Code 3845

Key Executives

Name Position
Guk-jin Kang Chief Executive Officer